Clinical

Mark J. DiNubile, MD, FIDSA, has been a founding member of the BioAegis team and key advisor to BioAegis Therapeutics  since its inception, providing leadership in clinical strategy, including serving as Chief Medical Officer. He brings to the table the rare combination of clinical and research expertise along with broad pharmaceutical industry experience, coupled with […]

Richard Wunderink, MD, is a professor of medicine in the Pulmonary and Critical Care Division of Northwestern University’s Feinberg School of Medicine and medical director of the MICU, Northwestern Memorial Hospital. His research and education focus includes pulmonary infections, especially ventilator-associated pneumonia and community-acquired pneumonia and sepsis. He served as co-chairman of the most recent

Dr. Wesley H. Self, MD, MPH, is the Vice Chair for Research in the Department of Emergency Medicine at Vanderbilt University Medical Center in Nashville, Tennessee, USA.  He is an emergency physician and researcher focused on the prevention and acute management of pneumonia, sepsis and influenza infections. He has published over 140 peer-reviewed publications and

Steve Opal, a leading figure in critical care medicine and infectious diseases, was a valued and integral advisor to BioAegis from its inception until his retirement. Sadly he passed in August 2024. His contributions to our program were immeasurable, and we deeply valued his unwavering support, expertise, and responsiveness. Always committed to advancing our work, Steve

Po-Shun Lee is pulmonary and critical care physician who worked in Dr. Stossel’s lab for 10 years and conducted rhu-pGSN in preclinical animal models. Dr. Lee has presented at the American Thoracic Society International Meeting on the subject of pGSN’s clinical and scientific implications. In 2004, Dr. Lee received an award from the New England